Literature DB >> 17728372

Systemic lupus erythematosus and infections: a retrospective study in Saudis.

H Al-Rayes1, R Al-Swailem, M Arfin, S Sobki, S Rizvi, M Tariq.   

Abstract

This study demonstrates demographic, clinical and laboratory characteristics with special reference to infections in Saudi patients with SLE. One-hundred and ninety-nine patients with SLE treated at Riyadh Armed Forces Hospital, Saudi Arabia over a period of 15 years (1990-2005) were retrospectively reviewed. There were 162 females and 37 males (4.4 : 1) with an average age of 35 years at onset of disease. Duration of diseases ranged from one to 23 years with a mean of 7.23 years. Some of the clinical characteristics of SLE patients observed were nephritis (53.7%), fever (53.26%), neuropsychological disorder (36.18%), malar/butterfly rash (27.6%), pulmonary disorder (22.6%), photosensitivity (21.6%), cardiac involvement (21.1%) and oral ulcers (19.09%). Infection was the major complication with 58.79% of SLE patient having suffered from various infections. A total of 22 species of pathogens including gram positive and gram negative bacteria, viruses and fungi were isolated from 117 SLE patients. Single to multiple episode of infection with various pathogens were recorded however, majority of patients harboured one or two species of pathogens. Bacterial infection was predominant (78.6%) followed by viral (28.2%) and fungal (28.2%) infections. Forty-four percent of SLE patients were found to be infected with organisms classified as opportunistic. The high incidence of infections in SLE patients may be attributed to the multiple intrinsic and extrinsic risk factors including deficiency of complement (C3 and C4), disease activity, renal impairment, use of glucocorticoid and cytotoxic drugs. It is concluded that more judicious use of corticosteroids and other immunosuppressive agents will be critical to limit the infections in SLE and a high alert and close monitoring of patients will ensure optimal patient outcome, both in terms of morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728372     DOI: 10.1177/0961203307079943

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

2.  Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj; Najma Khalil; Salman Al Saleh
Journal:  Rheumatol Int       Date:  2009-04-21       Impact factor: 2.631

3.  Clinical and Serologic Characteristics of Systemic Lupus Erythematosus in the Arab World: A Pooled Analysis of 3,273 Patients.

Authors:  Marwan Adwan
Journal:  Arch Rheumatol       Date:  2018-03-23       Impact factor: 1.472

4.  Herpes Zoster Infections in SLE in a University Hospital in Saudi Arabia: Risk Factors and Outcomes.

Authors:  Afsar Sayeeda; Hussain Al Arfaj; Najma Khalil; A S Al Arfaj
Journal:  Autoimmune Dis       Date:  2010-09-13

5.  Hospital-acquired infection in patients with systemic lupus erythematosus: a case-control study in a southern Chinese population.

Authors:  Zhongping Zhan; Minxi Lao; Fan Su; Dongying Chen; Liuqin Liang; Xiuyan Yang
Journal:  Clin Rheumatol       Date:  2017-11-27       Impact factor: 3.650

6.  Clinical correlates and outcomes in a group of Puerto Ricans with systemic lupus erythematosus hospitalized due to severe infections.

Authors:  Patricia Jordán-González; Lee Ming Shum; Lorena González-Sepúlveda; Luis M Vilá
Journal:  SAGE Open Med       Date:  2018-05-21

7.  Biopsy proven lupus nephritis in a black male patient in West Africa with systemic lupus erythematosus: case report.

Authors:  Elliot Koranteng Tannor; Kwame Yeboah-Mensah
Journal:  Pan Afr Med J       Date:  2018-11-22

8.  Noninfectious Causes of Fever in 128 Patients with Systemic Lupus Erythematosus.

Authors:  Feng Guo; Jianmei Chen; Yu Xie; Xueping Zhou
Journal:  Iran J Public Health       Date:  2019-01       Impact factor: 1.429

9.  The Systemic Lupus Erythematosus Infection Predictive Index (LIPI): A Clinical-Immunological Tool to Predict Infections in Lupus Patients.

Authors:  Jiram Torres-Ruiz; Nancy R Mejía-Domínguez; Alejandro Zentella-Dehesa; Alfredo Ponce-de-León; Sandra Rubí Morales-Padilla; Ricardo Vázquez-Rodríguez; Mario René Alvarado-Lara; Roberto Adrián Reyna-de-la-Garza; Miguel Tapia-Rodríguez; Guillermo Juárez-Vega; Javier Merayo-Chalico; Ana Barrera-Vargas; Jorge C Alcocer-Varela; Diana Gómez-Martín
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

10.  Apolipoprotein E Gene Polymorphisms in Saudi Patients with Systemic Lupus Erythematosus.

Authors:  Hannan Al-Rayes; Ghaleb Huraib; Saeed Julkhuf; Misbahul Arfin; Mohammad Tariq; Abdulrahman Al-Asmari
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.